Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021." MMWR Morb Mortal Wkly Rep. 2022;71(2):52-58.
"Peds Faculty Reference:
Mary Gaspers